Results 81 to 90 of about 851,197 (206)

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

open access: yesInternational Journal of COPD, 2017
Cheong-Ju Kim,1 Hyoung-Kyu Yoon,2 Myung-Jae Park,3 Kwang-Ha Yoo,4 Ki-Suck Jung,5 Jeong-Woong Park,6 Seong Yong Lim,7 Jae Jeong Shim,8 Yong Chul Lee,9 Young-Sam Kim,10 Yeon-Mok Oh,11 Song Kim,12 Chul-Gyu Yoo13 1Department of Internal Medicine, National ...
Kim CJ   +12 more
doaj  

Treatment of pulmonary exacerbations in cystic fibrosis. [PDF]

open access: yesCurr Opin Pulm Med, 2020
Ng C, Nadig T, Smyth AR, Flume P.
europepmc   +1 more source

Chronic bronchitis is an independently associated factor for more symptom and high-risk groups

open access: yesInternational Journal of COPD, 2016
Joon Young Choi,1 Hyoung Kyu Yoon,2 Seoung Ju Park,3 Yong Bum Park,4 Kyeong-Cheol Shin,5 Ju Ock Na,6 Kwang Ha Yoo,7 Ki-Suck Jung,8 Young Kyoon Kim,1 Chin Kook Rhee1 1Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal ...
Choi JY   +9 more
doaj  

Comparing Heterogenous Phenotypes of Chronic Obstructive Pulmonary Disease: Network Analysis and Penalized Generalized Linear Model

open access: yesInternational Journal of COPD
Hyeon-Kyoung Koo,1 Sung Jun Chung,1 Dongil Park,2 Ho Cheol Kim,3 Hyewon Seo,4 Hyun Jung Kim,5 Hyoung Kyu Yoon,6 Chin Kook Rhee,7 Kwang Ha Yoo,8 Deog Kyeom Kim9 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ilsan Paik
Koo HK   +9 more
doaj  

Home - About - Disclaimer - Privacy